Feasibility and Toxicity of Interval-Compressed Chemotherapy in Asian Children and Young Adults with Sarcoma

Feasibility and Toxicity of Interval-Compressed Chemotherapy in Asian Children and Young Adults with Sarcoma

Twelve Asian patients with sarcoma received interval-compressed (ic-) chemotherapy scheduled every 14 days with a regimen of vincristine (2 mg/m<sup>2</sup>), doxorubicin (75 mg/m<sup>2</sup>), and cyclophosphamide (1200–2200 mg/m<sup>2</sup>) (VDC) alternating wi...

Full description

Bibliographic Details
Main Authors:	Jia-Hui Huang, Shu-Huey Chen, Yu-Mei Liao, Yu-Chien Kao, Wan-Ling Ho, Hsi Chang, Min-Lan Tsai, Hsin-Lun Lee, Chia-Chun Kuo, Sung-Hui Tseng, Chia-Yau Chang, Kevin Li-Chun Hsieh, Long-Sheng Lu, Yin-Ju Chen, Jeng-Fong Chiou, Tsung-Han Hsieh, Yun-Ru Liu, Wayne Hsu, Wei-Tang Li, Yu-Chung Wu, Wei-Ciao Wu, Jinn-Li Wang, Jia-Jia Tsai, Keita Terashima, Chikako Kiyotani, Tai-Tong Wong, James S. Miser, Yen-Lin Liu
Format:	Article
Language:	English
Published:	MDPI AG 2023-04-01
Series:	Journal of Personalized Medicine
Subjects:	round cell sarcoma interval-compressed chemotherapy children adolescent and young adult VDC/IE granulocyte colony-stimulating factor
Online Access:	https://www.mdpi.com/2075-4426/13/4/668

Internet

https://www.mdpi.com/2075-4426/13/4/668